426 related articles for article (PubMed ID: 22722228)
21. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.
Pisters R; Lane DA; Nieuwlaat R; de Vos CB; Crijns HJ; Lip GY
Chest; 2010 Nov; 138(5):1093-100. PubMed ID: 20299623
[TBL] [Abstract][Full Text] [Related]
22. Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial.
Guo Y; Lane DA; Chen Y; Lip GYH;
Am J Med; 2020 Oct; 133(10):1195-1202.e2. PubMed ID: 32289310
[TBL] [Abstract][Full Text] [Related]
23. Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial.
Senoo K; Lip GY
Int J Cardiol; 2016 Oct; 221():379-82. PubMed ID: 27409565
[TBL] [Abstract][Full Text] [Related]
24. Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry.
Esteve-Pastor MA; Rivera-Caravaca JM; Roldán V; Sanmartin Fernández M; Arribas F; Masjuan J; Barrios V; Cosin-Sales J; Freixa-Pamias R; Recalde E; Pérez-Cabeza AI; Manuel Vázquez Rodríguez J; Ràfols Priu C; Anguita Sánchez M; Lip GYH; Marin F
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 9(1):38-46. PubMed ID: 36318457
[TBL] [Abstract][Full Text] [Related]
25. Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.
Hilkens NA; Algra A; Greving JP
Stroke; 2017 Nov; 48(11):3142-3144. PubMed ID: 28931618
[TBL] [Abstract][Full Text] [Related]
26. Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial.
Esteve-Pastor MA; Rivera-Caravaca JM; Shantsila A; Roldán V; Lip GYH; Marín F
Thromb Haemost; 2017 Dec; 117(12):2261-2266. PubMed ID: 29212113
[TBL] [Abstract][Full Text] [Related]
27. Comparative validation of HAS-BLED, GARFIELD-AF and ORBIT bleeding risk scores in Asian people with atrial fibrillation treated with oral anticoagulant: A report from the COOL-AF registry.
Chichareon P; Winijkul A; Lip GYH; Krittayaphong R
Br J Clin Pharmacol; 2023 Aug; 89(8):2472-2482. PubMed ID: 36942465
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
29. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.
Lefebvre MC; St-Onge M; Glazer-Cavanagh M; Bell L; Kha Nguyen JN; Viet-Quoc Nguyen P; Tannenbaum C
Can J Cardiol; 2016 Feb; 32(2):169-76. PubMed ID: 26277091
[TBL] [Abstract][Full Text] [Related]
30. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
[TBL] [Abstract][Full Text] [Related]
31. Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial.
Proietti M; Hijazi Z; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Lane DA; Oldgren J; Roldan V; Yusuf S; Wallentin L;
J Intern Med; 2018 Mar; 283(3):282-292. PubMed ID: 29044861
[TBL] [Abstract][Full Text] [Related]
32. Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study.
Lip GYH; Lane DA; Buller H; Apostolakis S
Chest; 2013 Dec; 144(6):1839-1847. PubMed ID: 24009027
[TBL] [Abstract][Full Text] [Related]
33. The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience.
Barnes GD; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Besley D; Krol GD; Froehlich JB; Kaatz S
Thromb Res; 2014 Aug; 134(2):294-9. PubMed ID: 24929840
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation.
Serna MJ; Rivera-Caravaca JM; Gonzalez-Conejero R; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Roldán V; Marín F
Eur J Clin Invest; 2018 Jun; 48(6):e12929. PubMed ID: 29577257
[TBL] [Abstract][Full Text] [Related]
35. Risk scores for major bleeding from direct oral anticoagulants: comparing predictive performance in patients with atrial fibrillation.
Campos-Staffico AM; Jacoby JP; Dorsch MP; Limdi NA; Barnes GD; Luzum JA
Res Pract Thromb Haemost; 2024 Jan; 8(1):102285. PubMed ID: 38292348
[TBL] [Abstract][Full Text] [Related]
36. Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation.
Guo Y; Zhu H; Chen Y; Lip GYH
Am J Med; 2018 Feb; 131(2):185-192. PubMed ID: 28943382
[TBL] [Abstract][Full Text] [Related]
37. How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
Steinberg BA; Shrader P; Kim S; Thomas L; Fonarow GC; Ansell J; Kowey PR; Singer DE; Gersh BJ; Mahaffey KW; Peterson ED; Piccini JP;
Am Heart J; 2016 Nov; 181():145-152. PubMed ID: 27823686
[TBL] [Abstract][Full Text] [Related]
38. Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation.
Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
Sci Rep; 2017 Sep; 7(1):12066. PubMed ID: 28935868
[TBL] [Abstract][Full Text] [Related]
39. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
[TBL] [Abstract][Full Text] [Related]
40. Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.
Lip GYH; Haguenoer K; Saint-Etienne C; Fauchier L
Chest; 2014 Sep; 146(3):719-726. PubMed ID: 24722973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]